BioQL Invest ApS: Financial statements 2023
CVR: 37755001
Source: annual report 2023, Danish Business Authority
01/01/2023 – 31/12/2023
BioQL Invest ApS (CVR 37755001) has filed annual accounts for 2023. In 2023, the company reported a gross profit of DKK -7,813 and a net result of DKK 2,601,533 compared with DKK 6,542,132 the year before. Equity in the 2023 report amounted to DKK 153,238. The solvency ratio was 95.3%.
- Gross Profit
- DKK -7,813
- Profit/Loss
- DKK 2,601,533
- Equity
- DKK 153,238
- Total Assets
- DKK 160,738
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2023 | - | -8K | 2.6M | 153K | - |
| 2022 | - | -8K | 6.5M | 6.7M | - |
| 2021 | - | -13K | 6.5M | 6.6M | - |
| 2020 | - | -299K | 15.8M | 7M | - |
| 2019 | - | -9K | -9K | 6.7M | - |
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record, straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2023
BioQL Invest ApS has published its annual report for 2022. Gross profit came to DKK -7,500, and the net result was DKK 6,542,132.
About BioQL Invest ApS
BioQL Invest ApS is a Danish company of the type Anpartsselskab based in Aarhus N, founded in 2016. The company is registered under the industry Investering for egen regning. The management consists of Mads Bredning Rydahl and Thomas Michael Redder Laursen. The company is owned by TMRL Holding ApS and Rydahl Holding ApS. According to the 2025 annual report, the company had an average of 0 employees. In 2025, the company reported a gross profit of DKK -9,737 and a net result of DKK -7,949 compared with DKK -4,372 the year before. Equity in the 2025 report amounted to DKK 70,917.